• Explore /
  • Poster
  • / Association between intra-tumoral microbiome and clinical benefit (CB) from immunotherapy (IO) in patients with metastatic renal cell carcinoma (mRCC).

Association between intra-tumoral microbiome and clinical benefit (CB) from immunotherapy (IO) in patients with metastatic renal cell carcinoma (mRCC).

Abstract Poster

Authors

null

Luis A Meza

City of Hope Comprehensive Cancer Center, Duarte, CA

Luis A Meza , Yongwook Choi , Jiaming Zhang , Nazli Dizman , Zeynep Busra Zengin , Hedyeh Ebrahimi , Regina Barragan-Carrillo , Joann Hsu , Neal Shiv Chawla , Alex Chehrazi-Raffle , Abhishek Tripathi , Daniela V. Castro , Benjamin D Mercier , Ameish Govindarajan , Agnes Chan , Nicholas Schork , Sara A. Byron , Sumanta Kumar Pal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4561)

DOI

10.1200/JCO.2023.41.16_suppl.4561

Abstract #

4561

Poster Bd #

53

Abstract Disclosures

Similar Posters

First Author: Joseph Vento

First Author: Eddy Saad

First Author: Pavlina Spiliopoulou

First Author: Aaron Scott Mansfield